Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Nils Homann"'
Autor:
Joseph Tintelnot, Alexander Stein, Salah-Eddin Al-Batran, Thomas Ettrich, Thorsten Götze, Barbara Grün, Georg Martin Haag, Vera Heuer, Ralf-Dieter Hofheinz, Nils Homann, Tobias Sebastian Bröring, Mariana Santos Cruz, Annika Kurreck, Sylvie Lorenzen, Nicolas Moosmann, Christian Müller, Markus Schuler, Gabriele Siegler, Mascha Binder, Eray Gökkurt
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundEsophagogastric adenocarcinoma (EGA) presents a substantial global health challenge as the number of cases continues to rise. The current standard approach for treating localized EGA involves a combination of triplet chemotherapy, which con
Externí odkaz:
https://doaj.org/article/9aca2f640fe447fba35289be96b705be
Autor:
Maria R. Gaiser, Sylvie Lorenzen, Kirsten Merx, Jörg Trojan, Janja Ocvirk, Thomas J. Ettrich, Salah‐Eddin Al‐Batran, Holger Schulz, Nils Homann, Hans‐Peter Feustel, Michael Schatz, Melanie Kripp, Nadine Schulte, Steffen Heeger, Soetkin Vlassak, Winfried Koch, Ralf‐Dieter Hofheinz
Publikováno v:
Cancer Medicine, Vol 8, Iss 9, Pp 4169-4175 (2019)
Abstract Acne‐like skin reactions frequently occur in patients undergoing treatment with drugs inhibiting the epidermal growth factor receptor. Recently, the effects of vitamin K1 containing cream (Reconval K1) as prophylactic skin treatment in add
Externí odkaz:
https://doaj.org/article/fff0c41466f24d5cbeb88fb44afecf15
Autor:
Ralf-Dieter Hofheinz, Kirsten Merx, Georg M. Haag, Christoph Springfeld, Thomas Ettrich, Kersten Borchert, Albrecht Kretzschmar, Christian Teschendorf, Gabriele Siegler, Matthias P. Ebert, Eray Goekkurt, Rolf Mahlberg, Nils Homann, Daniel Pink, Wolf Bechstein, Peter Reichardt, Hagen Flach, Timo Gaiser, Achim Battmann, Fuat S. Oduncu, Maria Loose, Disorn Sookthai, Claudia Pauligk, Thorsten O. Göetze, Salah-Eddin Al-Batran
Publikováno v:
Journal of Clinical Oncology. 40:3750-3761
PURPOSE High pathologic complete response (pCR) rates and comparably good survival data were seen in a phase II trial combining perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) chemotherapy with trastuzumab for resectable, es
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a634d226ebed830636c8e9affca6a97
https://doi.org/10.1200/jco.22.00380
https://doi.org/10.1200/jco.22.00380
Autor:
Salah-Eddin Al-Batran, Thorsten O. Goetze, Daniel W. Mueller, Arndt Vogel, Michael Winkler, Sylvie Lorenzen, Alexander Novotny, Claudia Pauligk, Nils Homann, Thomas Jungbluth, Christoph Reissfelder, Karel Caca, Steffen Retter, Eva Horndasch, Julia Gumpp, Claus Bolling, Karl-Hermann Fuchs, Wolfgang Blau, Winfried Padberg, Michael Pohl, Andreas Wunsch, Patrick Michl, Frank Mannes, Matthias Schwarzbach, Harald Schmalenberg, Michael Hohaus, Christian Scholz, Christoph Benckert, Jorge Riera Knorrenschild, Veit Kanngießer, Thomas Zander, Hakan Alakus, Ralf-Dieter Hofheinz, Claus Roedel, Manish A. Shah, Mitsuru Sasako, Dietmar Lorenz, Jakob Izbicki, Wolf O. Bechstein, Hauke Lang, Stefan P. Moenig
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background Historical data indicate that surgical resection may benefit select patients with metastatic gastric and gastroesophageal junction cancer. However, randomized clinical trials are lacking. The current RENAISSANCE trial addresses th
Externí odkaz:
https://doaj.org/article/5dc6e803a3084cd49c26c2fd2d3bd2f4
Autor:
Sylvie Lorenzen, Gertraud Stocker, Markus Möhler, Thorsten Oliver Götze, Alexander Stein, Eray Gökkurt, Georg Martin Haag, Salah-E. Albatran, Ralf Hofheinz, Nils Homann, Harald Schmalenberg, Michael K. Stahl, Kathrin Heinrich, Stefan Mönig, Peter Thuss-Patience
Publikováno v:
Der Onkologe. 28:23-29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e843448563e2bc49dfa768a9b4ebea5
https://doi.org/10.1007/s00761-021-01087-3
https://doi.org/10.1007/s00761-021-01087-3
Autor:
Thorsten O. Goetze, Ralf‐Dieter Hofheinz, Timo Gaiser, Harald Schmalenberg, Dirk Strumberg, Eray Goekkurt, Stefan Angermeier, Thomas Zander, Hans G. Kopp, Daniel Pink, Gabriele Siegler, Michael Schenk, Ferdinando de Vita, Gennaro Galizia, Evaristo Maiello, Wolf O. Bechstein, Moustafa Elshafei, Maria Loose, Disorn Sookthai, Tanita Brulin, Claudia Pauligk, Nils Homann, Salah‐Eddin Al‐Batran
This multicenter, randomized phase II/III study evaluated the addition of the vascular endothelial growth factor receptor-2 inhibitor ramucirumab to FLOT as perioperative treatment for resectable esophagogastric adenocarcinoma. Patients received eith
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dae7e5829d7cec46552135acd2092d2a
https://hdl.handle.net/11591/492768
https://hdl.handle.net/11591/492768
Autor:
Peter Malfertheiner, Alexander Stein, Ingo Tamm, Salah-Eddin Al-Batran, PaFLO investigators, Anica Högner, Nils Homann, Axel Hinke, Kirstin Breithaupt, Jens T. Siveke, Dietrich Gläser, Peter C. Thuss-Patience, Prisca Bartels, Mario Lorenz, Arndt Vogel
Publikováno v:
International Journal of Cancer. 150:1007-1017
VEGF inhibition in gastric cancer has a proven benefit in the second line setting. Pazopanib, an oral tyrosine kinase inhibitor, selectively inhibits VEGFR-1, -2 and -3, c-kit and PDGF-R resulting in inhibition of angiogenesis. This open-label random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf96675407fc47a29d81b1167977b1d9
https://doi.org/10.1002/ijc.33864
https://doi.org/10.1002/ijc.33864
Autor:
Jens Papke, Holger Schulz, Alexander Reichart, Jürgen Wehmeyer, Eike Gallmeier, Petra Büchner-Steudel, Martin Wolf, Lutz Jacobasch, Jan Wierecky, Klaus-Ulrich Däßler, Mark-Oliver Zahn, Salah-Eddin Al-Batran, Hans-Detlev Harich, Jörg Weniger, Lars Hahn, U. R. Peters, Dirk Behringer, Daniel Pink, Hans-Peter Feustel, Heinz-Gert Höffkes, Thomas Fietz, Marina Schaaf, Matthias Groschek, Claudia Pauligk, Arndt Vogel, Oliver Waidmann, Jens Uhlig, Steffen Dörfel, Ursula Vehling-Kaiser, G. Schuch, Wolfgang Blau, Helmut Forstbauer, Ludwig Fischer von Weikersthal, Martina Stauch, Arbeitsgemeinschaft Internistische Onkologie, Stephan Bildat, Jörg Schubert, Stefan Mahlmann, Michael Koenigsmann, Rudolf Schlag, Henning Eschenburg, Jörg Trojan, Albrecht Kretzschmar, Volker Kunzmann, Uwe Schwindel, Caroline Schönherr, Karin Waibel, Nils Homann, Ali Aldaoud, Thorsten Oliver Götze, Gerrit zur Hausen, Gabriele Margareta Siegler, Christoph Springfeld, Ralf-Dieter Hofheinz, Helmut Messmann, Marcus-A Wörns, Thomas J. Ettrich
Publikováno v:
International Journal of Cancer. 148:1478-1488
Few data exist on health-related quality of life (QoL) in patients with metastatic pancreatic cancer (mPC) receiving first-line chemotherapy (Awad L ZE, Mesbah M Boston, MA. Applying survival data methodology to analyze quality of life data, in Mesba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f49ed33d11961538a1152d28c1944a2
https://doi.org/10.1002/ijc.33336
https://doi.org/10.1002/ijc.33336
Autor:
Matthias Egger, Salah-Eddin Al-Batran, Jens T. Siveke, Susanna Hegewisch-Becker, Peter C. Thuss-Patience, Claudia Pauligk, Arndt Vogel, Thorsten Oliver Goetze, Stephan Probst, Nils Homann, Tobias Dechow, Sylvie Lorenzen, Holger Hebart, Hans-Georg Kopp, Kim Barbara Luley, Frank Kullmann, Joerg Seraphin, Michael Stahl, Jorge Riera Knorrenschild, Daniel Pink
Publikováno v:
International Journal of Cancer. 147:2493-2502
The RADPAC trial evaluated paclitaxel with everolimus in patients with advanced gastroesophageal cancer (GEC) who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen. Patients were randomly assigned to receive paclitax
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e360c6dc3a6b49c259aa27496df787f8
https://doi.org/10.1002/ijc.33025
https://doi.org/10.1002/ijc.33025
Autor:
Alexander Reichart, Nils Homann, Thomas J. Ettrich, Salah-Eddin Al-Batran, Volker Kunzmann, Gabriele Margareta Siegler, Jörg Trojan, Daniel Pink, Claudia Pauligk, Arndt Vogel, Rudolf Schlag, Wolfgang Blau, Marina Schaaf, Thorsten Oliver Goetze, Oliver Waidmann, Caroline Schoenherr, Heinz-Gert Hoeffkes, Gerrit zur Hausen, Helmut Messmann, Ralf Hofheinz
Publikováno v:
Web of Science
Publons
Publons
4625 Background: Gemcitabine and nab-paclitaxel (NPG) is standard first-line therapy for metastatic pancreatic cancer (mPC), but the pivotal study did not include quality of life (QoL) analyses. Methods: The QOLIXANE-PARAGON study started as a prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4c1107bb17f26d7044164ac4bcaf1ca
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/89663
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/89663